rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease
Clinical trial NCT02702518 · TERMINATED
Trial details
- NCT number
- NCT02702518
- Sponsor
- University of Illinois at Chicago
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-04-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.